About: Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1993 (uk) im Oktober 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1993 (ast) scientific article published on 01 October 1993 (en)
publication date	wds:Q72569978-9708B766-A7B0-4B6A-8BFB-8FCBFDE896AF
publication date	1993-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72569978-1217546D-6135-4ACC-94C6-CFBC018682FC
language of work or name	English
author name string	wds:Q72569978-484ADBA1-7AF8-432E-992C-DA955F17E3E9 wds:Q72569978-4CADC820-2504-4936-97E1-5AD5EFD01665 wds:Q72569978-5E0FB369-2EA9-469D-9DC5-7EC134DAE1AC wds:Q72569978-6E534AF3-6F00-425F-92BD-52A6BAEFF497 wds:Q72569978-8B216D5D-4F44-41BC-A176-19F773E53A51 wds:Q72569978-92A5168F-551C-4E8B-A979-02257C11930F wds:Q72569978-B80E404B-1E87-4E69-A3F3-9F7F948B6253 wds:Q72569978-CE3A5B1D-089F-4884-AD41-5775AC3ACF75
author name string	J D Cox M Roach R W Byhardt B Emami S Asbell T F Pajak J Pederson A H Russell
rdfs:label	Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (nl) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials (en)
skos:prefLabel	Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (nl) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials (en)
name	Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (nl) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials (en)
title	wds:Q72569978-4DACF9AD-D0E3-4CE9-B544-11666024111F
title	Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials (en)
page(s)	wds:Q72569978-89D0CAD7-1464-4D02-AE1D-EE12729B4318
page(s)	493-498
instance of	wds:Q72569978-10C27C1B-1CAD-40FF-96F9-9F65E116AAA6
instance of	scholarly article
PubMed ID	wds:Q72569978-FC254EC9-3E82-46D4-8550-F6CF4866DE8C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8226140
PubMed ID	8226140
published in	wds:Q72569978-69FDCE86-72AC-4ADD-B7AD-58728B073428
published in	International Journal of Radiation Oncology Biology Physics
issue	wds:Q72569978-FA1981E5-416A-4496-8021-D1B587552BEE
volume	wds:Q72569978-C1EE78A0-9212-4A0B-B6F4-87E53F6674B5
issue	3
volume	27
DOI	wds:Q72569978-6C82C1D9-D13A-4526-95C8-580411D97FB5
DOI	http://dx.doi.org/10.1016/0360-3016(93)90371-2
DOI	10.1016/0360-3016(93)90371-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72569978
is cites work of	Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee Palliative radiotherapy regimens for non-small cell lung cancer Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer Esophagitis, treatment-related toxicity in non-small cell lung cancer A new approach to dose escalation in non-small-cell lung cancer A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy Non-small cell lung tumors repopulate rapidly during radiation therapy Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer Accelerated hypofractionation for early-stage non-small-cell lung cancer The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk Multiple daily fractionation radiotherapy schedules in lung cancer. Radiation dose-volume effects in the esophagus A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients Dose timing in tumor radiotherapy: considerations of cell number stochasticity Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer Locally advanced non-small cell lung cancer The absence of an adverse effect of prolongation of radiation treatment of primary rectal adenocarcinoma First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation Chemoradiation schedules--what radiotherapy? Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitis. Optimizing chemotherapy and radiotherapy in locally advanced non-small cell lung cancer Radiation-induced esophagitis in lung cancer Chemoradiation for malignant epithelial tumors. Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer. Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer. Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas Limited-stage small cell lung cancer: local failure after concurrent chemoradiotherapy with use of accelerated hyperfractionation Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients [Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context] Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer. The role of radiotherapy and the value of combined treatment in lung cancer Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis. [Biological basis of combined chemo-radiotherapy. Applications to lung cancers]

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software